Technology Enhancement Grant (TEG)
The Technology Enhancement Grant (TEG) Program provides funding to North Carolina universities or other NC research institutions through their respective technology transfer or entrepreneurship partners. Under this program, awards of up to $75,000 are available to fund a commercially-focused research study to enhance the university’s licensing position for a commercially promising technology. The proposed project will ideally incorporate study endpoints designed to meet key milestones defined by potential licensees or industry-experienced technology development advisors.
To date, there have been 22 TEG awards to eight North Carolina institutions, totaling over $1M is funding.
Application Deadlines for FY2016
In order to be considered for funding in the current fiscal year (ending June 30, 2016):
The Tech Transfer Officer associated with a potential TEG project must request a preliminary consultation no later than Friday, April 8, 2016. Use the contact information provided.
Invited full proposals will be due by Wednesday, May 18, 2016. Details and instructions will be provided as part of the consultation.
Proposals to the TEG program must:
- Be submitted by (1) a technology transfer officer (or other official with licensing authority), or (2) a representative of a qualified entrepreneurial development organization, working on behalf of a North Carolina university or non-profit research institution.
- Pertain to a proprietary life sciences technology.
- Demonstrate that protection of licensable intellectual property (IP) has been initiated (minimally, the filing of a provisional patent).
- Attest that the IP rights are assigned to the applicant’s institution and have not been committed through license, option or letter-of-intent to license to any third-party at the time of application.
- Demonstrate that an initial review of the technology and its commercial opportunity has been reviewed by an independent technology development professional, or that a dialog with an independent potential licensee of the technology has been initiated.
The Biotechnology Center determines compliance with these requirements at its sole discretion on a case-by-case basis.
Permitted Use of Funds
TEG funds are intended to support activities directly associated with the execution of a research project that is designed to achieve a significant technical milestone in the evolution of a technology from basic science to licensable commercial product or service. Examples of such projects include establishment of proof-of-concept, lead identification or optimization, target validation, prototype development, preliminary safety testing, etc. Funding may be used to engage a non-academic contract research provider as needed. Please note that these funds may not be used to fund a basic science research study that is not directly tied to any commercial application or established licensing milestone.
Qualified applicants (as defined above) interested in applying for a TEG are invited to contact us to discuss the proposed project and the application procedures.
Pre-Proposal: Once eligibility and general fit for the program have been established, the applicant will be invited to submit a brief (2-page) pre-proposal describing the technology, its likely commercial application(s), IP and licensing status, licensing discussions to date, an overview of the proposed study, and how the study will directly impact the applicant’s ability to license the technology.
Full Proposal: Upon satisfactory review of the pre-proposal, the applicant will be invited to submit a full application. This application will expand upon each component described in the pre-proposal as well as provide a cover sheet, summary and detailed budget, and other supporting documentation as needed. The final proposal should be 10-15 pages in length.
Post Award Considerations
Fund distribution: TEG funds are distributed as reimbursements on an invoicing basis, requiring the submission of receipts to the Biotechnology Center’s Contracts & Grants Office.
Progress reports: Mid-term and final project reports are required which include a detailed update of progress against proposed milestones and time lines, as well as actual spending to date versus budget. The Biotechnology Center will actively monitor progress until the project is completed.